Cameron Tharp, MPH, RT(T)

255 posts

Cameron Tharp, MPH, RT(T) banner
Cameron Tharp, MPH, RT(T)

Cameron Tharp, MPH, RT(T)

@cameronatharp

radiation therapist/clinical instructor, epidemiologist, PhD student (epi) @uthealthsph

Houston, TX Katılım Temmuz 2023
106 Takip Edilen53 Takipçiler
Cameron Tharp, MPH, RT(T) retweetledi
Matt Spraker
Matt Spraker@SprakerMDPhD·
A surprise TAP episode! 🥳 Simul interviews @RicBertolo Don't miss his companion blog post on L'Affare Italiano
Matt Spraker tweet mediaMatt Spraker tweet media
English
2
4
12
1.1K
Cameron Tharp, MPH, RT(T) retweetledi
Matt Spraker
Matt Spraker@SprakerMDPhD·
Part 2 of the RPT TAP Mini-series is out now! Ana, Brandon (@brandonmancini), and Dustin are back for a show on the practical aspects of running a radiopharmaceutical clinic. Such as the importance of epicurean amino acids for Lutathera.
Matt Spraker tweet media
English
0
6
8
943
Cameron Tharp, MPH, RT(T)
Cameron Tharp, MPH, RT(T)@cameronatharp·
Had a blast during our first journal club! Lots of learning and great discussion. Will be making this a recurring event - if anyone wants to join me for a second, message me!
Cameron Tharp, MPH, RT(T)@cameronatharp

Hi all! Introducing a new project to the TAP lineup. Cam’s Journal Club Our first installment includes some very special guests (@StephDudzinski / Comron Hassanzadeh) to discuss the BART trial. Will be live and recorded - all are welcome! Be sure to sign up with link below.

English
0
0
0
23
Bobby Koneru, MD
Bobby Koneru, MD@KoneruMd·
We published a rebuttal to this meta-analysis. Should be published soon. It was conducted by a group of rheumatologists from Jordan, and there were several methodological concerns: heterogeneous joints were pooled together, and multiple relevant positive randomized trials were excluded, which likely affected the conclusions.
English
2
3
30
1.7K
Matt Spraker
Matt Spraker@SprakerMDPhD·
"This meta-analysis found that low-dose radiotherapy (LDRT) offers no significant benefit over sham treatment for osteoarthritis in terms of pain or function, despite mild adverse effects"
Matt Spraker tweet media
English
6
4
15
10.7K
Cameron Tharp, MPH, RT(T) retweetledi
Matt Spraker
Matt Spraker@SprakerMDPhD·
Announcing a new project... Cam Tharp's TAP Journal Club! First up, The BART Trial with very special guests. Live and recorded, all are welcome, sign up below 😍
Matt Spraker tweet mediaMatt Spraker tweet media
English
3
4
12
3.3K
Cameron Tharp, MPH, RT(T)
Cameron Tharp, MPH, RT(T)@cameronatharp·
Hi all! Introducing a new project to the TAP lineup. Cam’s Journal Club Our first installment includes some very special guests (@StephDudzinski / Comron Hassanzadeh) to discuss the BART trial. Will be live and recorded - all are welcome! Be sure to sign up with link below.
Cameron Tharp, MPH, RT(T) tweet mediaCameron Tharp, MPH, RT(T) tweet media
English
1
0
0
60
Cameron Tharp, MPH, RT(T) retweetledi
Matt Spraker
Matt Spraker@SprakerMDPhD·
Happy New Year Oncology Twitter! 🥳 Reminder: first round of travel award applications due in 10 days.
Matt Spraker tweet media
English
0
5
8
1.7K
Matt Spraker
Matt Spraker@SprakerMDPhD·
I neeeeed it
Matt Spraker tweet media
English
4
1
18
1.4K
Matt Spraker
Matt Spraker@SprakerMDPhD·
Today the drug Verzenio DMed me on LinkedIn 😎
Matt Spraker tweet media
English
1
0
1
464
Cameron Tharp, MPH, RT(T)
Cameron Tharp, MPH, RT(T)@cameronatharp·
@SprakerMDPhD @GammaTile Very engaging and exciting episode! Seems approachable for neurosurgeons and ROs alike. And logistically feasible for both. Looking forward to the trials you all discussed.
English
0
0
1
10
Cameron Tharp, MPH, RT(T) retweetledi
Matt Spraker
Matt Spraker@SprakerMDPhD·
TAP special #MedEd episode for #ASTRO25 is out! We host Mike and Simon, RO and NSGY experts in brachytherapy for brain tumors. Learned a ton working on this show, and Mike's creative trials have me excited about the future. Special thanks to @GammaTile for the support! 1/2
Matt Spraker tweet media
English
2
4
12
1.3K
Cameron Tharp, MPH, RT(T)
Cameron Tharp, MPH, RT(T)@cameronatharp·
@DrAndrewLoblaw @AmarUKishan @Soum_Roy_RadOnc . I want to ask to clarify - this study sources the RT cohort and surgical cohort from separate (though contemporaneous) trials? Initially I have concerns of the validity of comparing two unrelated samples. But happy to be educated otherwise
English
0
0
0
41
Dr. Andrew Loblaw
Dr. Andrew Loblaw@DrAndrewLoblaw·
In my mind the highest quality evidence we have of RT compared to RP for high risk prostate cancer. Findings are very consistent with @AmarUKishan centres of excellence data from JAMA Open (I think it was 2019 🤔) Well done @Soum_Roy_RadOnc and team!
Soumyajit Roy (Soum)@Soum_Roy_RadOnc

Want a Sunday morning reading with a sip of coffee? Here is one (in press) for #PCSM enthusiasts! sciencedirect.com/science/articl… Always grateful for the support and motivation from @DrSpratticus even during tough times and @yilun_sun for teaching me new things every time!!

English
3
10
39
3K